SAN DIEGO – Companion Medical has received CE Mark for the InPen system, a smart insulin pen paired with an integrated diabetes management app. While the system is currently available in the U.S., this clearance paves the way for launch in multiple international markets, said Sean Saint, CEO of Companion Medical, in a statement. “We look forward to introducing more sophisticated smart pen technology with integrated diabetes management tools to people with diabetes in Europe,” he said. “Our mission is to empower people living with diabetes and their health care providers with easy-to-use solutions that improve outcomes at a lower cost. The InPen system gives people with diabetes the tools they need to answer those questions precisely and accurately.” The system includes the ability for users to generate an Insights by InPen report, which displays aggregated glucose, insulin and meal data with detailed daily views, enabling providers to monitor glucose control and adherence patterns, identify the causes and effects of key decisions and make targeted improvements to therapy. Companion Medical plans to launch the InPen system in Europe next year.
You are here: / / InPen system receives CE Mark